India, Sept. 23 -- Continuing with its transformative efforts in the field of Artificial Intelligence in Pathology, SRL Diagnostics, today announced the second phase of their AI solution development engagement with a technology and data science grant from Microsoft's AI for Health program. While the phase 1 focused on AI models in Cytology and yielded an algorithm for screening of liquid based cytology slides for Cervical Cancer, the second phase will delve into AI models in Histopathology, majorly focusing on Breast, Colorectal and Prostate Cancers. As a part of this engagement, senior Histopathologists from SRL will not only lead and set processes for the AI algorithm development but will also provide research insights required for digita...